Skip to main content
Premium Trial:

Request an Annual Quote

Lion s Search for New CFO Nears End

NEW YORK, Jan. 21 - Lion Bioscience expects to end its search for a chief financial officer during the current quarter, the company said in a conference call last week.


The German bioinformatics giant began the search after CFO Klaus Sprockamp perished in the terrorist attacks on the World Trade Center on Sept. 11.

"Klaus was at a meeting with an investor who had offices on a high floor in the southern building when the attack occurred," Lion's CEO Friedrich von Bohlen said at the time.

Sprockamp, 42, was in the second tower when a pair of hijacked jumbo jets slammed into them, toppling them and killing more than 3,000 people. Von Bohlen said two other Lion employees were on their way to a later meeting at the World Trade Center but heard the news of the attack before arriving downtown.

"He [Sprockamp] was supposed to have a meeting later with two other guys from Lion and then the first plane crashed," von Bohlen said.

"Our thoughts are with his family," he added. "I have known Klaus for eight years. He was more than a colleague, he was a friend."

Sprockamp is survived by his wife and two children. He joined Lion, based in Heidelberg, as CFO in January 1999 after working as a consultant for the company.

Lion's corporate controller, Peter Willinger, has performed the CFO's duties in the interim.

Von Bohlen mentioned the impending end to the CFO search during a conference call announcing the company's acquisition of NetGenics.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.